Walleye Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-72,286
| Closed | -$57.1K | – | 2009 |
|
|
2025
Q1 | $57.1K | Sell |
72,286
-1,010,806
| -93% | -$799K | ﹤0.01% | 1617 |
|
|
2024
Q4 | $1.79M | Buy |
1,083,092
+1,015,483
| +1,502% | +$1.68M | ﹤0.01% | 737 |
|
|
2024
Q3 | $237K | Buy |
67,609
+49,009
| +263% | +$172K | ﹤0.01% | 1618 |
|
|
2024
Q2 | $61K | Buy |
+18,600
| New | +$61K | ﹤0.01% | 2129 |
|
|
2024
Q1 | – | Sell |
-39,229
| Closed | -$147K | – | 2738 |
|
|
2023
Q4 | $147K | Sell |
39,229
-62,756
| -62% | -$235K | ﹤0.01% | 1544 |
|
|
2023
Q3 | $216K | Sell |
101,985
-286,567
| -74% | -$608K | ﹤0.01% | 1463 |
|
|
2023
Q2 | $1.85M | Buy |
388,552
+71,245
| +22% | +$339K | 0.01% | 538 |
|
|
2023
Q1 | $1.81M | Buy |
317,307
+303,102
| +2,134% | +$1.73M | 0.03% | 555 |
|
|
2022
Q4 | $143K | Buy |
+14,205
| New | +$143K | ﹤0.01% | 1460 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2415 |
|
|
2022
Q2 | – | Sell |
-27,175
| Closed | -$1.05M | – | 2421 |
|
|
2022
Q1 | $1.05M | Buy |
+27,175
| New | +$1.05M | 0.03% | 593 |
|
|
2021
Q4 | – | Sell |
-4,505
| Closed | -$267 | – | 2103 |
|
|
2021
Q3 | $267 | Buy |
+4,505
| New | +$267 | 0.01% | 1047 |
|
|
2021
Q1 | – | Sell |
-8,410
| Closed | -$765 | – | 1216 |
|
|
2020
Q4 | $765 | Buy |
+8,410
| New | +$765 | 0.05% | 349 |
|